4
Changes in Ownership
TransMedics Group, Inc. Filed Acc 0000950170-24-043432
Chief Commercial Officer sold 19,900 shares at an average $90.35 ($1,798,002)
- Chief Commercial Officer acquired 19,900 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Khayal Tamer I · Chief Commercial Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-08 | Exercise or conversion : show line 1 in the form 10b5-1 | +4,388 | $16.14 | $70,822 | 29,573 | D |
| 2024-04-08 | Sale : show line 2 in the form 10b5-1 | −4,388 | $90.00 | $394,920 | 25,185 | D |
| 2024-04-09 | Exercise or conversion : show line 3 in the form 10b5-1 | +8,341 | $16.14 | $134,624 | 33,526 | D |
| 2024-04-09 | Exercise or conversion : show line 4 in the form 10b5-1 | +7,171 | $38.46 | $275,797 | 40,697 | D |
| 2024-04-09 | Sale : show line 5 in the form 10b5-1 | −10,532 | $90.14 | $949,354 | 30,165 | D |
| 2024-04-09 | Sale : show line 6 in the form 10b5-1 | −4,980 | $91.11 | $453,728 | 25,185 | D |
| Open-market sales · 19,900 sh · avg $90.35 · $1,798,002 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-04-08 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) | −4,388 | 8,341 | D |
| 2024-04-09 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Buy) | −8,341 | 0 | D |
| 2024-04-09 | Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (Right to Buy) | −7,171 | 61,368 | D |
Loading xslF345X05/ownership.xml…